These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32476048)

  • 1. Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.
    Karakucuk A; Celebi N
    Pharm Res; 2020 May; 37(6):111. PubMed ID: 32476048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermal flurbiprofen nanosuspensions: Optimization with design of experiment approach and in vitro evaluation.
    Oktay AN; Karakucuk A; Ilbasmis-Tamer S; Celebi N
    Eur J Pharm Sci; 2018 Sep; 122():254-263. PubMed ID: 29981401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.
    Oktay AN; Ilbasmis-Tamer S; Celebi N
    Pharm Dev Technol; 2019 Dec; 24(10):1278-1286. PubMed ID: 31535942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of nanosuspension formulation and process analysis in wet media milling using microhydrodynamic model and emerging characterization methods.
    Tian Y; Wang S; Yu Y; Sun W; Fan R; Shi J; Gu W; Wang Z; Zhang H; Zheng A
    Int J Pharm; 2022 Jul; 623():121862. PubMed ID: 35671851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac nanosuspension based gel for enhanced dermal delivery:
    Karakucuk A; Tort S; Han S; Oktay AN; Celebi N
    J Microencapsul; 2021 Jun; 38(4):218-232. PubMed ID: 33752553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of ritonavir nanosuspensions by microfluidization using polymeric stabilizers: I. A Design of Experiment approach.
    Karakucuk A; Celebi N; Teksin ZS
    Eur J Pharm Sci; 2016 Dec; 95():111-121. PubMed ID: 27181836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle Size Tailoring of Quercetin Nanosuspensions by Wet Media Milling Technique: A Study on Processing and Formulation Parameters.
    Cheshmehnoor P; Bolourchian N; Abdollahizad E; Derakhshi A; Dadashzadeh S; Haeri A
    Iran J Pharm Res; 2022 Dec; 21(1):e130626. PubMed ID: 36915402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
    Monteiro A; Afolabi A; Bilgili E
    Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions.
    Meng T; Qiao F; Ma S; Gao T; Li L; Hou Y; Yang J
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1867-1880. PubMed ID: 35362347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation.
    Pınar SG; Canpınar H; Tan Ç; Çelebi N
    Eur J Pharm Sci; 2022 Apr; 171():106123. PubMed ID: 35017012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
    Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.
    Singhal M; Baumgartner A; Turunen E; van Veen B; Hirvonen J; Peltonen L
    Int J Pharm; 2020 Sep; 587():119636. PubMed ID: 32659405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
    Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
    Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is roller milling - the low energy wet bead media milling - a reproducible and robust milling method for formulation investigation of aqueous suspensions?
    Zulbeari N; Holm R
    Int J Pharm; 2024 Feb; 651():123733. PubMed ID: 38142873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
    Qiao F; Zhao Y; Mai Y; Guo J; Dong L; Zhang W; Yang J
    Planta Med; 2020 May; 86(8):538-547. PubMed ID: 32294789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of formulation and process parameters for the production of carvedilol nanosuspension by wet media milling.
    Medarević D; Djuriš J; Ibrić S; Mitrić M; Kachrimanis K
    Int J Pharm; 2018 Apr; 540(1-2):150-161. PubMed ID: 29438724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.